Brazilian researchers said on Wednesday (Dec 23) the COVID-19 vaccine developed by China's Sinovac Biotech is more than 50 per cent effective based on trial data, but again withheld full results at the company's request, raising questions about transparency.
from Latest News https://ift.tt/2M3KxAO
Brazil institute says CoronaVac efficacy above 50%, but delays full results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment